Cut-Off Levels Clause Samples
The Cut-Off Levels clause establishes specific thresholds or limits beyond which certain actions, obligations, or liabilities no longer apply within a contract. In practice, this might mean that a party is only responsible for losses, claims, or performance up to a predetermined amount or time, after which their responsibility ceases. This clause is essential for clearly defining the boundaries of contractual risk and responsibility, thereby preventing disputes over excessive or unforeseen liabilities.
Cut-Off Levels. SAMHSA standards for cut-off levels will be complied with when applicable. The cut-off levels for both the screening and confirmatory tests shall be per Federal standards as determined by the U. S. Department of Health and Human Services ("DHHS"). Only tests which are positive pursuant to the SAMHSA standards shall be reported to the Medical Review Officer as positive. A .04 blood/alcohol level or above shall be considered to be positive.
Cut-Off Levels. Cut-off levels for a positive test are either those established by NIDA/SAMHSA for the drugs for which NIDA/SAMHSA has made such recommendations, or as established through negotiations with the Coalition for those drugs on the list for which NIDA/SAMHSA has not established cut-off level(s). For purposes of this agreement, the cut-off levels are as follows: Drug Initial Screen Confirming Test (EMIT) (GC/MS) Amphetamines (NIDA/SAMHSA) 1000 ng/ml 500 ng/ml Benzodiazapines 300 ng/ml 300 ng/ml Barbiturates 300 ng/ml 300 ng/ml Cocaine (NIDA/SAMHSA) 300 ng/ml 150 ng/ml Methadone 300 ng/ml 300 ng/ml Drug Methaqualone Initial Screen 300 ng/ml Confirming Test 300 ng/ml Opiates (NIDA/SAMHSA) 300 ng/ml 300 ng/ml P.C.P. (NIDA/SAMHSA) 25 ng/ml 25 ng/ml T.H.C. (NIDA/SAMHSA) 100 ng/ml 15 ng/ml Breath Alcohol .05 g/dL .05g %
Cut-Off Levels. Cut-off levels for a positive test are either those established by NIDA/SAMHSA for the drugs for which NIDA/SAMHSA has made such recommendations, or as established through negotiations with the Coalition for those drugs on the list that NIDA/SAMHSA has not established cut-off level(s). For purposes of this agreement, the cut-off levels are as follows: Drug Initial Screen Confirming Test (EMIT) (GC/MS) Amphetamines (NIDA/SAMHSA) 1000 ng/ml 500 ng/ml Benzodiazapines 300 ng/ml 300 ng/ml Barbiturates 300 ng/ml 300 ng/ml Cocaine (NIDA/SAMHSA) 300 ng/ml 150 ng/ml Methadone 300 ng/ml 300 ng/ml Methaqualone 300 ng/ml 300 ng/ml Opiates (NIDA/SAMHSA) 300 ng/ml 300 ng/ml P.C.P. (NIDA/SAMHSA) 25 ng/ml 25 ng/ml T.H.C. (NIDA/SAMHSA) 100 ng/ml 15 ng/ml Section 6. Laboratory Reporting
A. The laboratory report, whether negative or positive, shall be returned to the medical facility from which the specimen came.
B. The medical facility shall include the laboratory report in the applicant's medical examination record when the record is returned to the County Occupational Health Programs Unit for final review.